Trial intelligence / Profile preview

Opioid-free Anaesthesia for Postoperative Delirium in Elderly GI Surgery

NCT06958393Phase 4Not yet recruiting

Sponsor
Shandong Provincial Qianfoshan Hospital
Start
May 2025
Primary completion
Jan 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine, esmolol and esketamine in postoperative delirium (POD) (2 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoint: Incidence of Postoperative Delirium at 7 days. Planned start May 2025; status: not yet recruiting.

02

Drugs

dexmedetomidineesmololesketamine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT06958393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06958393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call